Back to Search
PHILIP STELLA, M.D.
M.D.
Medical Oncology Physician
NPI: 1194725671Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301040900(MI)
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension.
PMID 14736447·J Am Coll Cardiol·2004
8-other
Concurrent pheochromocytoma, diabetes insipidus and cerebral venous thrombosis--a possible unique pathophysiological mechanism.
PMID 10809818·Nephrol Dial Transplant·2000
5-case
Urinary NGAL marks cystic disease in HIV-associated nephropathy.
PMID 19628667·J Am Soc Nephrol·2009
7-preclinical
A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC).
PMID 19188136·Ann Oncol·2009
3-trial
Optical coherence tomography: new (near-infrared) light on stent implantation?
PMID 19679572·Heart·2009
8-other
A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer.
PMID 19114685·J Clin Oncol·2009
3-trial
Quantitative coronary angiography in the current era: principles and applications.
PMID 19627430·J Interv Cardiol·2009
6-review
Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography.
PMID 18678291·Am J Cardiol·2008
8-other
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
PMID 18707985·Lancet·2008
4-observational
Spontaneous coronary artery dissection: current insights and therapy.
PMID 18958258·Neth Heart J·2008
8-other
One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial.
PMID 19110784·EuroIntervention·2008
3-trial
Bortezomib, paclitaxel, and carboplatin as a first-line regimen for patients with metastatic esophageal, gastric, and gastroesophageal cancer: phase II results from the North Central Cancer Treatment Group (N044B).
PMID 18449005·J Thorac Oncol·2008
3-trial
Relationships among endogenous ouabain, alpha-adducin polymorphisms and renal sodium handling in primary hypertension.
PMID 18398333·J Hypertens·2008
8-other
Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry.
PMID 18360855·Catheter Cardiovasc Interv·2008
3-trial
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.
PMID 19064574·Cancer Epidemiol Biomarkers Prev·2008
4-observational
Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.
PMID 17686802·Heart·2008
8-other
Comment and reply on: Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir.
PMID 17588305·Curr Med Res Opin·2007
8-other
Stent thrombosis in real-world patients: a comparison of drug-eluting with bare metal stents.
PMID 18176640·Neth Heart J·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5301 E HURON RIVER DR, STE C139
YPSILANTI, MI 48197 - Phone
- (734) 712-1000
Quick Facts
- NPI
- 1194725671
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile